Skip to main content

Thrombolysis

Thrombolysis uses clot-dissolving medicine, including tPA and TNK to help restore blood flow during an acute ischemic stroke.

  • Stroke & Cerebrovascular Disorders

    We have decades of experience caring for patients with stroke & cerebrovascular disorders, pioneering minimally invasive treatments and leading research for new treatments to improve patient outcomes.

What Is Thrombolysis?

Thrombolysis is a treatment that uses medicine to dissolve a blood clot that is blocking blood flow. In cerebrovascular care, it is most often used for an acute ischemic stroke, which happens when a clot blocks an artery that supplies the brain. Two commonly used thrombolytic medicines are alteplase (tPA) and tenecteplase (TNK).

When used in the right situation and within a limited time window, thrombolysis may help reopen the blocked blood vessel, limit damage to brain tissue and improve recovery. A physician will quickly evaluate symptoms, imaging, timing and overall health to decide whether this treatment may be appropriate.

Why Choose Baptist Health?

Baptist Health Brain & Spine Care provides coordinated evaluation and treatment for urgent neurologic conditions such as stroke. For patients who may need thrombolysis, care decisions depend on fast assessment, brain imaging and close teamwork among emergency and stroke specialists.

Because thrombolysis is time-sensitive, access to rapid diagnosis matters. Baptist Health experts focus on timely evaluation, clear communication and a treatment plan tailored to the patient’s symptoms, imaging findings and medical history. Additional treatment, including mechanical thrombectomy, may also be considered for some patients.

Why Choose Baptist Health?

How It Works

Thrombolysis uses medicine delivered through an IV to break down a clot that is blocking blood flow. In stroke care, the goal is to restore circulation to the brain as quickly as possible.

Two medicines that may be used are tPA and TNK. tPA usually refers to alteplase, a clot-dissolving medicine that has been used in stroke care for many years. TNK refers to tenecteplase, a newer clot-dissolving medicine in the same drug family.

Both medicines work by helping break down the clot so blood can flow to the brain again. One key difference is how they are given.

  • Alteplase (tPA) is typically started with an IV bolus and then continued as an IV infusion over about an hour.
  • Tenecteplase (TNK) is generally given as a single IV bolus. TNK also stays active in the body longer and is more fibrin-specific, which means it is designed to target clot material more selectively. Because of these features, TNK may be easier to give quickly in some emergency settings.

When each medicine is used depends on the clinical situation, timing, imaging and physician judgment. The goal with either medicine is the same: to restore blood flow as quickly and safely as possible.

Who May Benefit

Thrombolysis may help some people with symptoms of an acute ischemic stroke who arrive for evaluation within an appropriate treatment window. It may be considered when symptoms are disabling, when brain imaging supports treatment and when the care team determines the potential benefits outweigh the risks.

Not everyone with stroke symptoms is a candidate. Thrombolysis is generally not used for hemorrhagic stroke, which is caused by bleeding in or around the brain, or when certain medical factors increase the risk of complications.

Benefits and Risks

Potential Benefits

Possible benefits of thrombolysis include:

  • Faster restoration of blood flow to the brain
  • A better chance of limiting permanent brain injury
  • Potential improvement in function, speech, movement or independence
Potential Risks

Possible risks depend on the patient’s condition, but may include:

  • Bleeding, including serious bleeding in the brain
  • Allergic or medication-related reactions
  • Swelling or other complications that require close monitoring

Your care team will explain why thrombolysis is or is not recommended in your situation.

What to Expect

  • The team works quickly to confirm whether symptoms may be caused by ischemic stroke. This usually includes a physical exam, review of when symptoms started, brain imaging, blood pressure checks and blood tests. Some medicines or medical conditions may affect whether thrombolysis is safe.

  • If thrombolysis is recommended, the medicine is given through an IV. The care team monitors neurological status, blood pressure and any signs of complications during and after treatment. TNK is generally given as a single IV dose. tPA is usually started with a small IV dose followed by an infusion over about an hour. Which medicine is used depends on the stroke team’s protocol, the patient’s condition, imaging findings and whether other treatment such as mechanical thrombectomy is being planned.

  • Patients are closely monitored in the hospital. Follow-up imaging and neurological exams help the team assess response and watch for bleeding or other complications. The next steps may include stroke prevention planning, rehabilitation and follow-up care.

Recovery

Recovery after thrombolysis varies. Some people improve quickly, while others need additional treatment, therapy or longer recovery support. Recovery depends on how quickly blood flow was restored, the size and location of the stroke, and the patient’s overall health.

Frequently Asked Questions

  • Thrombolysis is the overall treatment approach. tPA, also called alteplase, and TNK, also called tenecteplase, are two clot-dissolving medicines that may be used to perform thrombolysis for certain patients with acute ischemic stroke.

  • Thrombolysis is highly time-sensitive. The care team evaluates when symptoms began, imaging results and other medical factors to decide whether treatment may still help. In general, faster treatment gives the best chance of protecting brain tissue.

  • Both medicines dissolve blood clots, but they are not exactly the same. tPA usually refers to alteplase, which is given as an IV bolus followed by an infusion. TNK refers to tenecteplase, which is usually given as a single IV bolus. TNK may be easier to give quickly, while alteplase remains a well-established treatment.

  • Candidates are usually people with suspected acute ischemic stroke who arrive within an appropriate time window and do not have factors that make treatment unsafe. A physician must confirm eligibility.

  • That decision depends on the patient’s symptoms, brain imaging, timing, bleeding risk, hospital protocols and whether other urgent treatment is planned. Some teams may prefer TNK because it can be given in one IV dose. Others may use alteplase based on established protocols or patient-specific factors.

  • No. Thrombolysis is generally used for ischemic stroke caused by a blocked blood vessel. It is not used for hemorrhagic stroke caused by bleeding.

  • The most serious risk is bleeding, including bleeding in the brain. The care team weighs this risk against the potential benefit of restoring blood flow.

  • The team may recommend other care based on the cause and severity of symptoms. For some patients, this may include supportive stroke care, monitoring or other procedures.

  • The treatment itself is usually not painful beyond IV placement and routine monitoring. Most patients are focused on urgent stroke symptoms and rapid evaluation.

  • Possibly. Even when treatment helps restore blood flow, some patients benefit from physical, occupational or speech therapy during recovery.

News & Podcasts

News

View All
How to Recognize Your Body's 'I'm Stressed!' Warning Signs October 9, 2026

Stress does not always announce itself with a racing mind or a feeling of being overwhelmed. Sometimes, the first clues come from the body: a headache that keeps returning, tight shoulders, an...

Roundup: Low Cognitive Test Scores Linked to Higher Stroke Risk; and More News October 9, 2026

Low Cognitive Test Scores in Your 60s May Indicate Higher Future Stroke Risk Adults in their 60s who perform lower than their peers on tests of memory, thinking and mental processing speed may face a...

Baptist Health Breaks Ground on New Home of Kenneth C Griffin Neuroscience Institute October 7, 2026

Baptist Health has broken ground on the new home of Baptist Health Kenneth C. Griffin Neuroscience Institute, marking a major investment in the future of brain and spine care, neuroscience research...

Podcasts

View All
Migraine Relief: What Helps, What Doesn’t, and What’s New June 9, 2026
Stroke Symptoms at Any Age: What You Need to Know May 27, 2026
Brain Tumors: What to Watch For and When to Get Help May 13, 2026

Have Questions? Let’s Talk.

We’re here to support you every step of the way. If you need help or want to learn more, we’re just a phone call away.

Language Preference / Preferencia de idioma

I want to see the site in English

Continue In English

Quiero ver el sitio en Español

Continuar en español